This gene therapy nanomaterial achieves knockdown of CD47 and overexpression of IL‐9 in GBM cells, thus promoting both phagocytoses of tumors by microglia and specific killing of GBM by T cells.[88] (b) Phenotype conversion. This evidence concerns the gene IL9 and glioblastoma.